PMWC 2018 Duke SpeakersProgram Full Speaker ListLuminary Award Jeffrey I. Gordon Washington University in St. Louis Mary V. Relling St. Jude Children’s Research HospitalProgram Committee Robert M. Califf Duke University School of Medicine Geoffrey Ginsburg Duke University School of Medicine Ralph Snyderman Duke University Ken Tindall North Carolina Biotechnology Center Tal Behar PMWC IntlCurrent Speakers Omar Abdul-Rahman University of Nebraska Medical Center Jeffrey Balser Vanderbilt Aris Baras Regeneron Genetics Center Dawn Barry LunaDNA Christopher Bolen Womble Bond Dickinson Dani Bolognesi Istari Oncology Ebony Boulware Duke University Don Brown LifeOmic Robert M. Califf Duke University School of Medicine Nicholas Campbell Median Technologies Timothy L. Cannon Inova Health System Gunnar Carlsson Ayasdi Tom Caskey Baylor College of Medicine Brian Caveney LabCorp Rita R. Colwell University of Maryland Cathleen Colon-Emeric Duke University School of Medicine Edward Conner Sangamo Therapeutics Patrick Conway Blue Cross and Blue Shield of North Carolina Jason Crites IBM Manoj Dadlani CosmosID Lawrence David Duke University Stephanie Devaney NIH Holli Hutcheson Dilks Sarah Cannon Research Institute Nevenka Dimitrova Philips Healthcare Amos Dor Applied Materials Nicholas Dracopoli Personal Genome Diagnostics David Ellis SmartGene, Inc. William E. Evans St. Jude Children’s Research Hospital Andrew Eye ClosedLoop.ai Jonathan Franca-Koh National Cancer Institute Stacey Gabriel Broad Institute Charles Gersbach Duke University Jennifer Giltnane Genentech Geoffrey Ginsburg Duke University School of Medicine Manuel J. Glynias GenomOncology, LLC Jeffrey I. Gordon Washington University in St. Louis William Haas Essential Health Solutions Susanne Haga Duke University School of Medicine Eden Haverfield Invitae William Hearl Immunomic Therapeutics Madhuri Hegde PerkinElmer Mohsen Hejrati Clusterone David Hong Karius Howard Jacob AbbVie Charles Jaffe HL7 Derek Jantz Precision BioSciences Sally John Biogen Inc. Wendell Jones Q² Solutions | EA Genomics Shahar Keinan Cloud Pharmaceuticals Mickey Kertesz Karius Juthika Khargharia SAS Nikole Kimes Siolta Therapeutics Mary E. Klotman Duke University School of Medicine Raj Krishnan Biological Dynamics Myla Lai-Goldman GeneCentric Therapeutics Robert S. Langer MIT Guido Lanza Numerate Inc. Catherine Reinis Lucey UCSF Mark R. Miglarese Caris Life Sciences Natalia Mitin HealthSpan Dx Mike Nall Biocept, Inc. L. Staton Noel III Panaceutics Alexandra Villarreal O’Rourke Womble Bond Dickinson Michael Olivier Wake Forest School of Medicine Arthur Pappas Pappas Capital Jungyeon Park WeCancer Philip Parks Exact Sciences Corporation Michael Pellini Foundation Medicine Michael Pencina Duke University School of Medicine Eric Perakslis Datavant Scott K. Pruitt Merck Research Laboratories Kevin Puylaert SOPHiA GENETICS Mary V. Relling St. Jude Children’s Research Hospital Ty Ridenour RTI International Isidore Rigoutsos Thomas Jefferson University Caroline Savello Color Genomics Svati Shah Duke University School of Medicine Atul Sharan CellMax Life Vandana Shashi Duke University School of Medicine Lauren Silvis FDA Ralph Snyderman Duke University Ben Solomon GeneDx Richard Spero Redbud Labs Ryan Swenerton Natera Daniel Tiber Roche Alexander Tropsha UNC-Chapel Hill Ephraim Tsalik Predigen, Inc. Hannah Valantine NIH Vijetha Vemulapalli Berg LLC J. Craig Venter J. Craig Venter Institute (JCVI) Benjamin Vincent The University of North Carolina at Chapel Hill John Walker uMETHOD Health, Inc. Thomas Wechsler Sangamo Therapeutics Richard West Baebies
